An interventional study of monitoring physiological and movement-based data in Radar, Monitoring and Physiologic Monitoring, sponsored by Rukiye Kokkiz. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-01.
Sponsored by Rukiye Kokkiz · Not applicable, Interventional, and Diagnostic
This study aims to develop a millimeter wave radar technology-based patient monitoring system that allows for the monitoring of physiological and movement-based data in healthcare settings without requiring physical contact with individuals. The study will involve the creation of hardware and software components for processing, analyzing, and converting signals obtained through radar sensors into clinically meaningful data.
Rukiye Kokkiz is the lead sponsor of 3 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The developed prototype device will collect respiratory rate, heart rate, blood pressure, and cardiac output data from six healthy individuals acting as researchers.
Device: monitoring physiological and movement-based data
monitoring physiological and movement-based data
Data collection with the prototype device.
The developed prototype device will collect respiratory rate, heart rate, blood pressure, and cardiac output data from six healthy individuals acting as researchers.
Time frame: 3 months
No study locations are listed for this record.
This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.